Basic HTML Version
First-in-man experience with the DES Orsiro in the
treatment of patients with single de novo coronary
artery lesions (BIOFLOW-I)
Martial Hamon, MD, FESC
University Hospital of Caen
Normandy, France
ClinicalTrials.gov Identifier: NCT01214148